U.S. Congress Proposes Bills to Strengthen Pharma Competition, Promote InnovationAuthorized Generics, Biosimilars, Branded Generics, Clinical Trials, Congress, Drug Price Reform, Drug Prices, Drug Pricing, Generic Substitution, Generics, House Committee on Oversight and Government Reform, Interchangeable Biosimilars, Pricing, R&D, R&D Investment ReturnOn Thursday, members of both the U.S. House of Representatives and the U.S. Senate introduced legislation that targets efforts that have limited competition, which keeps the price of prescription drugs high. Read more April 8, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/04/BiospaceUSCapitol.com_.jpg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-04-08 12:16:032022-04-08 12:58:31U.S. Congress Proposes Bills to Strengthen Pharma Competition, Promote Innovation